Literature DB >> 12218131

Peptidic termini play a significant role in TCR recognition.

Bo Wang1, Ashawni Sharma, Robert Maile, Mohamed Saad, Edward J Collins, Jeffrey A Frelinger.   

Abstract

TCR recognition of class I MHC is dependent on the composition of the antigenic peptide and the MHC. Single amino acid substitutions in either the MHC or the peptide may dramatically alter recognition. While the major interactions between TCR and the peptide/MHC complex appear to be focused on the complementarity-determining region (CDR)3, it is also clear from the cocrystal structure of class I MHC and TCR that the amino and carboxyl ends of the peptide may play a role through interactions with the CDR1. In this work we show that gp33 variants substituted at the peptidic termini at the putative CDR1 contact regions show improved recognition in B6 mice. The rank order of recognition is different using the P14 transgenic T cells, suggesting that one reason for improved recognition is a change in the TCR repertoire that recognizes the peptide. However, the affinity of the TCR by some of the peptide/MHC complex with increased recognition is improved, as shown by increased tetramer binding to P14 T cells. These substitutions at the termini of the peptide-binding cleft cause localized conformational changes as seen by changes in mAb binding and crystallographic structures. The different peptide structures also show different conformations in the center of the peptide, but these are shown to be energetically similar and thus most likely have no significance with respect to TCR recognition. Therefore, small conformational changes, localized to the CDR1 contact regions, may play a significant role in TCR recognition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218131     DOI: 10.4049/jimmunol.169.6.3137

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

2.  Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Authors:  Judith Racape; Francine Connan; Johan Hoebeke; Jeannine Choppin; Jean-Gérard Guillet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

Authors:  Mahesh Yadav; Suchit Jhunjhunwala; Qui T Phung; Patrick Lupardus; Joshua Tanguay; Stephanie Bumbaca; Christian Franci; Tommy K Cheung; Jens Fritsche; Toni Weinschenk; Zora Modrusan; Ira Mellman; Jennie R Lill; Lélia Delamarre
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

4.  Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction.

Authors:  Mazell M Tetruashvily; John W Melson; Joseph J Park; Xiaoyu Peng; Lisa M Boulanger
Journal:  Mol Cell Neurosci       Date:  2016-01-21       Impact factor: 4.314

5.  Structural and kinetic basis for heightened immunogenicity of T cell vaccines.

Authors:  Ji-Li Chen; Guillaume Stewart-Jones; Giovanna Bossi; Nikolai M Lissin; Linda Wooldridge; Ed Man Lik Choi; Gerhard Held; P Rod Dunbar; Robert M Esnouf; Malkit Sami; Jonathan M Boulter; Pierre Rizkallah; Christoph Renner; Andrew Sewell; P Anton van der Merwe; Bent K Jakobsen; Gillian Griffiths; E Yvonne Jones; Vincenzo Cerundolo
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

6.  Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution.

Authors:  Michael J Miley; Ilhem Messaoudi; Beatrix M Metzner; Yudong Wu; Janko Nikolich-Zugich; Daved H Fremont
Journal:  J Exp Med       Date:  2004-11-22       Impact factor: 14.307

7.  Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination.

Authors:  Adil Doganay Duru; Renhua Sun; Eva B Allerbring; Jesseka Chadderton; Nadir Kadri; Xiao Han; Kaliroi Peqini; Hannes Uchtenhagen; Chaithanya Madhurantakam; Sara Pellegrino; Tatyana Sandalova; Per-Åke Nygren; Stephen J Turner; Adnane Achour
Journal:  PLoS Pathog       Date:  2020-05-04       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.